
Evaluation of dabigatran, rivaroxaban and apixaban target-specific assays in a multicenter French study
Keywords: DOAC measurement; PT; aPTT; Direct factor Xa inhibitor; Direct thrombin inhibitor; Anti-Xa activity; Ecarin assay; Dilute thrombin time;